School of Medicine

Washington University School of Medicine is joining the National Institutes of Health (NIH)’s Bridge2AI program, an estimated $130 million initiative. One project aims to develop a framework for using artificial intelligence to diagnose disease based on the sound of patients’ voices.

A center in the Institute of Clinical and Translational Sciences received a grant establishing the School of Medicine as a coordinating center for the Short-Term Research Experience Program to Unlock Potential. STEP-UP is a National Institutes of Health (NIH) program to introduce scholars underrepresented in medicine to medical research.

Using Fitbits and a novel machine learning model, a multi-institutional team led by Washington University’s Chenyang Lu is ushering in the next step in personalization for treatment of depression.

To develop guidelines to evaluate artificial intelligence (AI) in nuclear-medicine imaging, an interdisciplinary team established by Richard L. Wahl, MD, director of Mallinckrodt Institute of Radiology (MIR) and led by Abhinav Jha, assistant professor at the McKelvey School of Engineering, published Recommendations for Evaluation of AI for Nuclear Medicine in the Journal of Nuclear Medicine.

Cynthia E. Rogers, MD, the Blanche F. Ittleson Professor of Psychiatry at the School of Medicine, has been named an Emerging Leader in Health and Medicine Scholar by the National Academy of Medicine.

Ryan Emenecker, a postdoctoral researcher at Washington University School of Medicine, has won the 2022 Regeneron Prize for Creative Innovation.

Researchers led by the McKelvey School of Engineering’s Hong Chen recently invented a technique for generating ultrasound waves that can self-bend, like a rainbow.

The world’s first nasal vaccine for COVID-19 was approved Sept. 6 in India for emergency use. The vaccine, called iNCOVACC, is based on technology licensed from Washington University and developed in collaboration with Bharat Biotech International Limited in India.

Ismael Seáñez received a five-year $1 million grant from the National Institutes of Health (NIH) to lead interdisciplinary spinal cord injury research.

Men with low testosterone who develop COVID-19 are at elevated risk of becoming seriously ill and ending up in the hospital, according to a study by researchers at Washington University School of Medicine and Saint Louis University School of Medicine.